# Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome

Study · id `cardio:ct-nct05536271` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05536271](<https://clinicaltrials.gov/study/NCT05536271>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05536271

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 127 participants.

## Technical summary

Registry record NCT05536271. Allocation not applicable; no masking; primary purpose treatment. Start 2021-09-01 (actual); primary completion 2022-06-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 127 participants (enrolled count; ClinicalTrials.gov record NCT05536271, source copy `cardio:ctgov-nct05536271-2023-06-07`, retrieved 2026-10-31)
- Started: 2021-09-01 (actual) (ClinicalTrials.gov record NCT05536271, source copy `cardio:ctgov-nct05536271-2023-06-07`, retrieved 2026-10-31)
- Primary completion: 2022-06-01 (actual) (ClinicalTrials.gov record NCT05536271, source copy `cardio:ctgov-nct05536271-2023-06-07`, retrieved 2026-10-31)
- Completion: 2022-08-16 (actual) (ClinicalTrials.gov record NCT05536271, source copy `cardio:ctgov-nct05536271-2023-06-07`, retrieved 2026-10-31)
- Countries: Egypt (ClinicalTrials.gov record NCT05536271, source copy `cardio:ctgov-nct05536271-2023-06-07`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05536271-2023-06-07`, retrieved 2026-10-31)

## The registry's words

- Brief title: Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Bisoprolol Fumarate
- Lead sponsor: Damanhour University
- Lead sponsor class: OTHER
- Collaborator: Alexandria University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Bisoprolol (`cardio:bisoprolol`)
- Registry intervention is a member of this class by a sourced record link: Beta-blockers (drug class) (`cardio:beta-blockers`)
- Registry lists this organization as the lead sponsor: Damanhour University (`cardio:org-damanhour-university`)
- Registry lists this organization as a collaborator: Alexandria University (`cardio:org-alexandria-university`)

## Provenance

Content hash: d6280ae4b9071dca8ff8a82f8c98b9b3791f40e1978035e474dd85c993a1c597
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
